Matthew Shair, a director at $NUVL, sold 108 shares of the company on 01-27-2025 for an estimated $9,180. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.0% of their shares of this class of stock. Following this trade, they now own 218,522 shares of this class of $NUVL stock.
$NUVL Insider Trading Activity
$NUVL insiders have traded $NUVL stock on the open market 119 times in the past 6 months. Of those trades, 0 have been purchases and 119 have been sales.
Here’s a breakdown of recent trading of $NUVL stock by insiders over the last 6 months:
- JAMES E FLYNN has made 0 purchases and 2 sales selling 2,000,000 shares for an estimated $195,500,000.
- ANDREW A. F. HACK sold 1,250,000 shares for an estimated $110,000,000
- JAMES RICHARD PORTER (President and CEO) has made 0 purchases and 15 sales selling 125,301 shares for an estimated $10,904,925.
- ALEXANDRA BALCOM (Chief Financial Officer) has made 0 purchases and 21 sales selling 54,016 shares for an estimated $4,817,871.
- HENRY E. PELISH (Chief Scientific Officer) has made 0 purchases and 14 sales selling 45,778 shares for an estimated $4,335,333.
- DEBORAH ANN MILLER (Chief Legal Officer) has made 0 purchases and 20 sales selling 27,964 shares for an estimated $2,414,315.
- DARLENE NOCI (Chief Development Officer) has made 0 purchases and 20 sales selling 24,016 shares for an estimated $2,079,978.
- MATTHEW SHAIR has made 0 purchases and 22 sales selling 12,000 shares for an estimated $1,083,465.
- CHRISTOPHER DURANT TURNER (Chief Medical Officer) has made 0 purchases and 3 sales selling 4,016 shares for an estimated $320,009.
- EMILY CONLEY sold 3,334 shares for an estimated $283,456
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NUVL Hedge Fund Activity
We have seen 120 institutional investors add shares of $NUVL stock to their portfolio, and 76 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 786,257 shares (+8.9%) to their portfolio in Q3 2024, for an estimated $80,434,091
- BLACKROCK, INC. added 601,355 shares (+19.9%) to their portfolio in Q3 2024, for an estimated $61,518,616
- COMMODORE CAPITAL LP removed 547,756 shares (-36.8%) from their portfolio in Q3 2024, for an estimated $56,035,438
- PERCEPTIVE ADVISORS LLC added 430,158 shares (+16.9%) to their portfolio in Q3 2024, for an estimated $44,005,163
- PARADIGM BIOCAPITAL ADVISORS LP added 428,322 shares (+9.4%) to their portfolio in Q3 2024, for an estimated $43,817,340
- WELLINGTON MANAGEMENT GROUP LLP added 400,402 shares (+65.5%) to their portfolio in Q3 2024, for an estimated $40,961,124
- VANGUARD GROUP INC added 357,609 shares (+9.5%) to their portfolio in Q3 2024, for an estimated $36,583,400
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.